851 studies found for:    "Hepatitis B"
Show Display Options
Rank Status Study
21 Completed Simvastatin for the Treatment of Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Simvastatin;   Drug: Tenofovir;   Drug: Entecavir
22 Completed KRN7000 in Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: KRN7000
23 Completed Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Drug: Specific intravenous anti-hepatitis B immunoglobulin
24 Recruiting Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Conditions: Hepatitis B Chronic Infection;   Pregnancy
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: placebo
25 Terminated Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects
Condition: Chronic Hepatitis B
Interventions: Drug: albinterferon alfa-2b;   Drug: Pegasys®
26 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & amp;  Emtricitabine;   Drug: Tenofovir
27 Completed Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
28 Withdrawn Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention: Drug: Prednisone Priming
29 Completed Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
Condition: Chronic Hepatitis B
Interventions: Drug: Lamivudine plus Polyethylene glyco-interferon alfa-2b;   Drug: Lamivudine
30 Recruiting Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
Conditions: Hepatitis B;   Cholestasis
Interventions: Drug: Ademetionine   2;   Drug: Ademetionine 1;   Drug: Ademetionine 3
31 Terminated ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Conditions: HBe Negative Chronic Hepatitis B;   Hepatitis B Viral Infection
32 Unknown  The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
Conditions: Hepatitis B;   Hepatocellular Carcinoma
Intervention: Procedure: radiofrequency ablation
33 Completed Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules
Condition: Hepatitis B
Intervention: Biological: Vaccination to prevent hepatitis B virus infection
34 Completed Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
Condition: Hepatitis B
Interventions: Drug: Hepsera;   Drug: Hepsera and lamivudine
35 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
36 Completed Duration of Long-term Immunity After Hepatitis B Virus Immunization
Condition: Hepatitis B
37 Completed Hepatitis B and HIV Co-Infection in Patients in Uganda
Conditions: Hepatitis B;   HIV Infections
38 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
39 Active, not recruiting Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Entecavir, Adefovir
40 Recruiting Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Conditions: Hepatitis B, Chronic;   Liver Fibrosis
Intervention: Drug: Treatment with entecavir(Baraclude®)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years